A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity  by Deneault, Eric et al.
ResourceA Functional Screen
to Identify Novel Effectors
of Hematopoietic Stem Cell Activity
Eric Deneault,1 Sonia Cellot,1 Ame´lie Faubert,1 Jean-Philippe Laverdure,1 Me´lanie Fre´chette,1 Jalila Chagraoui,1
Nadine Mayotte,1 Martin Sauvageau,1 Stephen B. Ting,1 and Guy Sauvageau1,2,*
1Molecular Genetics of Stem Cells Laboratory, Institute of Research in Immunology and Cancer (IRIC), University of Montreal,
Montreal, Quebec H3C 3J7, Canada
2Division of Hematology and Leukemia Cell Bank of Quebec (BCLQ), Maisonneuve-Rosemont Hospital, Montreal, Quebec H1T 2M4, Canada
*Correspondence: guy.sauvageau@umontreal.ca
DOI 10.1016/j.cell.2009.03.026SUMMARY
Despite tremendous progress made toward the iden-
tification of the molecular circuitry that governs cell
fate in embryonic stem cells, genes controlling this
process in the adult hematopoietic stem cell have
proven to be more difficult to unmask. We now report
the results of a novel gain-of-function screening
approach, which identified a series of 18 nuclear
factors that affect hematopoietic stem cell activity.
Overexpression of ten of these factors resulted in an
increased repopulating activity compared to unma-
nipulated cells. Interestingly, at least four of the 18
factors, Fos, Tcfec, Hmgb1, and Sfpi1, show non-
cell-autonomous functions. The utilization of this
screeningmethodtogetherwith thecreationofadata-
base enriched for potential determinants of hemato-
poietic stem cell self-renewal will serve as a resource
to uncover regulatory networks in these cells.
INTRODUCTION
The mature cell contingent of adult hematopoietic tissue is
continuously replenished during the life span of an animal by
the periodic supplies from hematopoietic stem cells (HSCs)
that reside in a niche. To maintain blood homeostasis, these
primitive cells rely on two critical properties, namely multipo-
tency and self-renewal. The former enables differentiation into
multiple lineages, while the latter ensures preservation of HSC
fate upon cellular division. By definition, a self-renewal division
implies that an HSC is permissive to cell cycle entry, while
restrained from engaging in differentiation, apoptosis or senes-
cence pathways. The transcriptional regulatory network of
HSC self-renewal still remains largely undefined, an observation
that contrasts with that of embryonic stem cells (ESCs), for which
self-renewal is increasingly dissected molecularly (reviewed in
Jaenisch and Young, 2008). Only a few nuclear factors have
been documented as promoters of HSC expansion (reviewed
in Hai-Jiang et al., 2008). Of these factors, Hoxb4 and its deriva-tives (Hoxa9, NA10HD) are among the most potent and best
documented (Ohta et al., 2007; Thorsteinsdottir et al., 2002).
The differential pace of progress propelling the fields of ESC
and HSC research reflects, at least in part, seminal discoveries
that rendered ESCs more amenable to large-scale experiments.
First, although only observable as a transient state in vivo, ESCs
derived from the inner cell mass can bemaintained in vitro as cell
lines by the addition of serum (as a source of bone morphogenic
protein [BMP]) and leukemia inhibitory factor (LIF). Attempts to
maintain or expand HSCs ex vivo as homogenous populations
have been modest, and successful development of cell lines
have not been reported, hampering harvest of large numbers
of HSCs. Second, a stringent surrogate marker to follow the
HSC multipotent state, comparable to the pluripotency tags of
Oct4, Nanog, AP, or SSEA1 for ESCs, is still lacking. Albeit
yielding small numbers, current cell sorting strategies allow
isolation of HSC populations to near purity (Kiel et al., 2005).
However, shortly upon facing the selective pressures of in vitro
culture conditions, changes in cell phenotype are observed
(Uchida et al., 2004), impeding HSC tracking in this context.
The gold standard to confirmHSC activity for cells kept in culture
remains the in vivo competitive repopulation assay. Importantly,
generation of retroviral vectors provides highly efficient tools to
infect and thereby modulate gene expression in both ESCs
and HSCs (Root et al., 2006).
The demonstration that in mouse fibroblasts a given nucleocy-
toplasmic configuration, or state, can be reverted to a stem cell
phenotype by the enforced overexpression of four defined
nuclear factors, i.e., Oct4, Sox2, c-Myc, and Klf4, stands as
a conceptual breakthrough (Takahashi and Yamanaka, 2006).
Indeed, the ability to create induced pluripotent stem cells, or
iPS cells, suggests that a putative role for as yet unidentified
nuclear factors in orchestrating HSC fate is probable. With this
mindset, interrogation of stem cell expression profile databases
was undertaken. From this data set, a listing and ranking of
nuclear factors whose transcripts were abundant in stem cell-
enriched subpopulations was generated. Over 100 of the high-
est-scoring candidates were then functionally tested in HSCs,
using a high-throughput overexpression in vitro to in vivo assay
tailored to circumvent current limitations imposed by the biology
of HSCs. As detailed below, these studies serve as a further stepCell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc. 369
Figure 1. Experimental Design of Nuclear Factors
Screening Strategy
(A) A list of candidate genes (see Table S1 for the complete list)
was generated as described in the Results. The 689 nuclear
factors were subsequently ranked on the basis of an algorithm
that stratifies them according to properties predictive of self-
renewal regulation. The highest scoring candidates (n = 139)
were further selected for functional assessment with a retro-
viral overexpression approach. Of these, 104 were tested
(see ‘‘*’’ in Table S1), and the remaining 35 genes were
excluded for technical reasons.
(B) The coding sequence of each tested candidate was subcl-
oned into one out of three modified MSCV vectors, each
containing a different reading frame (pKOF-1, -2 and -3).
Respective retroviral producers were seeded in a single well
of a 96-well plate and cocultured for 5 days with 1500
CD150+CD48Lin freshly sorted bone marrow CD45.1+
cells. Immediately upon infection (day 0), one-eighth of each
well was transplanted into two congenic recipient mice along
with 23 105 total BM cells (CD45.2+). A similar assay, this time
with three recipient mice, was performed after an additional
week of ex vivo culture (day 7), on which the screen was
performed.
(C) Expression of candidate proteins in retroviral-producing
cells was tested by western immunoblotting and revealed
with an anti-FLAG antibody. A list of predicted and observed
molecular weights for most proteins tested in this screen is
available in Table S2. NS, nonspecific signal; *, example of
a protein that could not be detected by western blot analysis
(see also Table S2).
(D) Range of retroviral gene transfer efficiencies of sampled
candidate genes on the basis of EGFP expression assessed
at day 4 of HSC culture (only eight representatives shown;
dashed line represents average on all 104 genes).forward into the exploration of the molecular circuitry that
governs HSC self-renewal.
RESULTS
Selection and Ranking of Candidate Genes
As a corollary of ESC studies, it can be proposed that HSC fate is
also controlled by a series of master regulators analogous to
Oct4 and several subordinate effectors, providing sound basis
for the generation of a stem cell nuclear factors database.
Toward this end, we created a database consisting of 689
nuclear factors (Figure 1A; Table S1 available online; see also
http://www.bioinfo.iric.ca/self-renewal/) considered as candi-
date regulators of HSC activity. This list was predominantly
derived from microarray gene expression profiling of normal
and leukemia stem cells, including our recently generated
FLA2 leukemia (1 in 1.5 cells is a leukemia stem cell, A.F. and
G.S., unpublished data). Genes obtained after a review of the
literature on stem cell self-renewal were also added to the list
(see legend of Table S1 for references). Genes in this database
were then ranked from 1 (lowest priority) to 10 (highest priority)
on the basis of three factors: differential expression between
primitive and more mature cell fractions (e.g., HSC-enriched),
expression level (high levels were given highest priority), and
the consistency of findings between data sets. Genes with a370 Cell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc.score of 6 and above (n = 139) were selected for functional
studies, of which 104 were tested (Figure 1A; see also asterisks
in Table S1). Interestingly, the list of selected candidates is highly
enriched for bona fide regulators of hematopoiesis, namely Egr1,
Gata2, Sfpi1 (PU.1), Foxo1,Meis1,Myb, Hoxa9, and Runx1 (Min
et al., 2008; reviewed in Lessard et al., 2004). However, the
majority of the other candidates have no reported function in
primitive hematopoietic cells.
Design and Principle of the Screen
The screening protocol is outlined in Figure 1B. In brief, high-titer
retroviruses were produced in 96-well plates seeded with viral
producer cells using an optimized procedure. Protein extracts
derived from producer cells in each of the 104 wells were
analyzed by western blotting, which confirmed the presence of
a FLAG protein in 89% of the cases (Figure 1C provides eight
representative candidates; details for all 104 genes are listed in
Table S2, sixth column), with 92% of these proteins showing
the expected molecular size (Table S2, compare the fifth and
sixth columns). CD150+CD48Lin mouse bone marrow (BM)
cells were infected during 5 days and transplanted at two
different time points (i.e., day 0 and day 7 in Figure 1B). Under
these conditions, the average gene transfer to the cultured
CD150+CD48Lin cells was at 49% ± 31% (Figure 1D provides
eight representative candidates; details for all 104 genes are
Figure 2. Identification of Positive Candidates with Hoxb4-like
Activity
(A) Estimation of HSC activity during viral transduction and culture. Lines show
estimation of HSC activity in recipients of day5, day 0, or day 7 bone marrow
(BM) cells transduced with Hoxb4 (red) or control vector (black). Two indepen-
dent experiments were performed with purified and whole bone marrow cells
for Hoxb4, and three with purified BM cells for controls. Extrapolation of HSC
numbers in recipients (y axis) was based on relative reconstitution levels
observed in the CRU assay performed with our starting HSC subpopulation
in Figures S2B–S2C. In all experiments, each mouse received eight equivalent
day 5 HSCs (representing 100% HSC activity and evaluated by CRU assay)
and 20 equivalent fresh competitor HSCs (see legend of Figure S2 for details).
Cutoff for identification of Hoxb4-like candidates used in the primary screen/
validation experiments (shaded area) is set on the basis of the standard devi-
ation/error of the mean reconstitution level observed in multiple recipients of
Hoxb4-transduced HSCs. Cutoff for other less potent candidates (area
between dotted lines) is used only in validation experiments and is based on
statistical difference between candidates and vector control.
(B) Graft-derived hematopoiesis was evaluated at 4 week intervals in recipi-
ents of cultured HSCs during the primary screen. As a set of reference values,
the left panel indicates peripheral blood reconstitution levels from mice trans-
planted with cells from cultures initiated with a positive regulator of self-
renewal (Hoxb4) in relation to values observed with control vectors (mean of
pKOF-1, -2 and -3), all after 7 days of culture. Mean reconstitution level valueslisted in Table S3, second column). Harvested cells from each
well were transplanted into irradiated recipients together with
23 105 congenic BMcells. Donor-derived peripheral white blood
cell reconstitution was assessed after short (4 and 8 weeks) and
long (12 and 16 weeks) periods of time after transplantation.
Previous results obtained from several in vivo transplantation
experiments, using freshly transduced CD150+CD48Lin cells,
revealed marked interrecipient heterogeneity in hematopoietic
tissue reconstitution for a given candidate gene, thereby raising
the critical issue of signal-to-noise discrimination. Optimization
of this parameter was crucial for increasing the specificity of
the screen while limiting to a minimum the number of mice that
would be required. Toward this goal, we confirmed previous
findings (Antonchuk et al., 2002) showing that the activity of
Hoxb4-overexpressing HSCs is enhanced during short-term
cultures (see red line in Figure 2A). For control (i.e., vector-trans-
duced) HSCs, we also confirmed a noticeable decline in their
activity during the 7 day culture (black line in Figure 2A). Interest-
ingly, this HSC activity was preserved during the infection period
(Figure 2A). Importantly, we found that recipients of these
cultured control CD150+CD48Lin cells showed much less
variation in blood cell reconstitution levels than those trans-
planted with ‘‘day 0’’ cells (compare error bars at day 0 versus
day 7 on the black line in Figure 2A). In search for additional
genes withHoxb4-like activity, it appears that the signal-to-noise
ratio is thus substantially enhanced by keeping cells in such
cultures (Figure 2A). For this reason, the primary screen was
performed with cells harvested at day 7 of the culture (see
‘‘Screen’’ in Figure 1B).
Primary Screen and Validation
Theminimal cutoff level for selection of positive candidates in the
primary screen was set on the basis of the standard deviation of
the mean reconstitution level observed in multiple recipients of
Hoxb4-transduced CD150+CD48Lin cells (Figure 2B, see
also shaded area in Figure 2A). We therefore expected the newly
identified candidates to be equivalent to, or more potent than,
for each of the 104 tested candidates (at day 7) are compiled and presented in
the middle panel, with the established cutoff level for a gain-of-function
readout. Candidates clustering above the cutoff level for identification of
Hoxb4-like genes (shaded area in Figure 2A), corresponding to 30%
CD45.1+ donor-derived cells in the primary screen, were selected for the vali-
dation experiments (upper-right panel), while those below were disregarded
(lower-right panel). One candidate (Hes1) was eliminated on the basis of the
marked reduction in repopulation noted between early and late time points
(upper line in lower-right panel). Values are presented as mean ±SEM of inde-
pendent experiments (n) for the left panel (n = 2 for Hoxb4 and n = 3 for control
vector; mean of three mice per experiment) and as mean ±SD for the middle
and right panels (n = 3 mice for each candidate cDNA). Note that several
mice were eliminated at 12 or 16 weeks after transplantation because they
did not meet our criteria for hit selection (see also Table S3, ninth and tenth
columns).
(C) Validation experiments confirming ten Hoxb4-like genes and eight other
less potent candidates. p values were established at the 16 weeks after trans-
plantation time point. Values are shown as mean ±SEM. The number of inde-
pendent experiments (n) per candidate gene equals four, except for control
vectors (n = 8); Sox4, Zfp472, Xbp1, and Hnrpdl (n = 5); and Hoxb4, Cnbp,
Ski, and Prdm16 (n = 3). For each experiment, a mean of three mice per
gene was evaluated. cand., candidates.Cell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc. 371
Figure 3. HSC Activity Is Enhanced by Overexpression of the Newly
Identified Hoxb4-like Genes
(A) Percentages of donor-derived blood cells at 16 weeks after transplantation
in primary mice recipients of day 7 culture cells (experiments in Figure 2C) for
the ten identified hits. Bars at the far left show values for freshly purified
CD150+CD48Lin cells, day 0 control cells (empty vector), and day 7 control
andHoxb4-transduced cells, as references. The shaded area representsmean
reconstitution levels observed in mice transplanted with day 0 control-trans-
duced HSCs, ±1 SEM. Reconstitution values falling within this range are
considered to reflect HSC activity derived from an injected dose of HSCs
equivalent to culture input numbers, i.e., 8 competitive repopulation units
(CRUs) (see Figure S2C). d-5, day 5; d0, day 0; d7, day 7. Note that two
different cDNA were tested for Trim27 (see Figure S5).
(B) The mean activity of stem cells (MAS) was calculated from the data ob-
tained in (A). As previously established, the MAS is equivalent to repopulation
units (RUs) divided by CRUs (Ema and Nakauchi, 2000), where RU represents
the donor-derived reconstitution level divided by the competitor-derived
reconstitution level. MAS index was normalized to 1 for freshly sorted cells
and excluded the gene transfer efficiency in its estimation for the candidate
genes. In cases where gene transfer is low, this could lead to underestimated
values. Grafts overexpressing genes shown in red and marked by an asterisk
give rise to aMAS significantly higher than day 0 control grafts (p% 0.05). Note
that values are presented as theMAS relative to that of fresh cells (d5), which
was set at a value of 1. d-5, day 5; d0, day 0; d7, day 7.
(C) p values derived fromMASvalues presented in (B) comparing data obtained
from control vectors (day 0 or 7) and validated genes. Day 0 p values framed in
red (penultimate column) mirror the order and color code of candidate genes
presented in (B) and are %0.05. In comparison, day 7 p values are listed in
the adjacent column.; n, number of independent experiments; d0, day 0; d7,
day 7.Hoxb4 in inducing enhanced HSC activity. With this
criterion, a total of 18 hits were identified for a frequency of
17% (18/104; Figure 2B, upper-right panel; see also Table S3,
tenth column). These 18 hits included Cnbp, Erdr1, Fos,
Hdac1, Hmgb1, Hnrpdl, Klf10, Pml, Prdm16, Sfpi1 (PU.1), Ski,
Smarcc1 (Baf155), Sox4, Tcfec, Trim27, Vps72, Xbp1, and
Zfp472.372 Cell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc.To validate the primary screen, we repeated the procedure
described in Figure 1B in several independent experiments
and confirmed ten primary hits (upper panels in Figure 2C; details
in Table S3). From left to right and top to bottom, genes are pre-
sented on the basis of the level of statistical significance reached
in these experiments, in comparison to control vector: Hoxb4
(positive control, gray in Figure 2C), Smarcc1, Vps72, Fos,
Trim27, Sox4, Klf10, Ski, Prdm16, Erdr1, and Sfpi1, for a positive
predictive value (PPV) of 56%. Although the other eight candi-
dates failed to demonstrate Hoxb4-like activity (i.e., shaded
area in Figure 2A), it is noteworthy that they all significantly
enhanced HSC activity to level above that detected with
vector-transduced cells (see ‘‘other less potent candidates’’ in
Figures 2A and 2C).
We then explored whether the ten newly identified Hoxb4-like
genes are endogenously expressed in populations highly en-
riched in HSCs. To test this, we sorted cells from hematopoietic
tissues isolated from unmanipulated mice sacrificed at three
different developmental stages including E14.5 fetal liver (HSC-
enriched subset number 1) and postnatal bone marrow, where
a switch between cycling (3 weeks, subset number 2) and quies-
cent (4 weeks, subset number 3) HSCs has been described
(Bowie et al., 2006). In line with the selection of these factors in
our database, all ten genes are highly expressed in HSC-
enriched populations with endogenous levels exceeding those
of TATA binding protein (TBP), used as endogenous control
(see relative threshold cycle [Ct] values for all HSC-enriched
subsets in Figure S1A). Interestingly, most of these genes are
expressed at higher levels in HSC-enriched populations than in
total tissues (total bone marrow or fetal liver, Figure S1B). This
observation is most prominent in the fetal liver-derived HSC-
enriched subset (upper panel Figure S1B). We next verified the
level of overexpression achieved for each of these genes after
retroviral infection in sorted CD150+CD48LincKit+Sca1+ BM
cells and documented relative increases in mRNA levels
that could be as low as 3-fold (e.g., Smarcc1) to as high as
1000-fold and above (e.g., Fos; Figure S1C).
Most Genes Identified Confer Enhancement
in HSC Activity
One important question is whether the newly identified genes
enhance or simply maintain input stem cell activity. To address
this point, we compared the reconstitution levels by donor cells
isolated (at day 7) from test cultures to that observed in recipients
which received an equivalent number of freshly purified
CD150+CD48Lin cells. As shown in Figure 3A, baseline long-
term HSC (LT-HSC) activity (Sauvageau et al., 2004), measured
at 12%–16% reconstitution level (see left black bars in Fig-
ure 3A), was essentially preserved during the 5 day infection
period and set the baseline values for maintenance of input
HSCactivity (shadedarea inFigure3A). Fromthis,wecoulddeter-
mine that all validated hits conferred a net increase in HSC recon-
stitution activity above that determined for fresh cells (Figure 3A).
In order to further quantitate the impact of our validated genes
on HSC activity, we used the mean activity of stem cell (MAS)
index as reported by Ema andNakauchi (2000). This value, which
provides a measure of the proliferative output per LT-HSC, is
easily applicable to our culture condition since they were all
Figure 4. In Vitro Differentiation, Survival,
and Proliferation Profiles of Cultured Cells
(A) Morphological analysis of cytological prepara-
tions of the starting HSC fraction overexpressing
most of identified primary hits at day 7 of culture.
Proportions of immature (blasts: black arrow in
middle-left insert) versus terminally differentiated
cells (neutrophils, monocytes and masts cells:
black arrows in upper-left insert) for respective
cultures are depicted in the right panel. A field
comprising 100 cells was examined per indepen-
dent experiment (n), and values are presented as
mean; n = 3, except for vector (n = 6) and Hoxb4,
Ski, Tcfec, Sfpi1, and Hmgb1 (n = 1). The shaded
area represents the mean of vector plus two stan-
dard deviations. Note that a vast majority of the
less significant hits described in Figure 2C are
included in this study (i.e., Tcfec, Hmgb1, Cnbp,
Xbp1, Hnrpdl, and Hdac1). BM, bone marrow.
(B) Annexin V and PI stains were used to determine
the fraction of cell death in cultures initiated with
our validated hits and the less potent gene candi-
dates (Tcfec and Hmgb1) as well as empty vector,
Hoxb4, or NA10HD, serving as controls. Assess-
ment was performed at the day 4 time point of
culture. Values are presented as mean ±SD of two independent experiments (n), where n represents the analysis of 30,000 cells. * p% 0.05.
(C) Cell proliferation was assessed by flow cytometry-based cell counts (y axis) at day 4 of cultures. Analyses were performed for the same gene candidates as in
(B). Values are presented as mean ±SD of two independent experiments. * p% 0.05.initiated with a constant number of input LT-HSC measured at
62 competitive repopulating units (CRU) per well (see Figures
S2B–S2C for CRU assessment). The MAS was 3-fold higher
for Hoxb4-transduced cells than for controls (Figure 3B). Simi-
larly, the MAS varied between 2.8 (Vps72) and 4.9 (Trim27) for
all ten hits identified in our screen (Figure 3B). Except for Sfpi1
(p = 0.18), all values reached statistical significance (see p values
in red in Figure 3C).
Impact of Candidate Genes on Cell Proliferation,
Death, and Differentiation In Vitro
There is growing evidence to suggest that HSC self-renewal
involves the active repression of a differentiation program, which
is coupled to cell division (Cellot and Sauvageau, 2007). In
support of this, we recently found thatHoxb4- orNA10HD-trans-
duced cells, which actively undergo in vitro self-renewal divi-
sions, show evidence of differentiation arrest (Figure 4A, left
panels) (Cellot et al., 2007). We investigated whether our newly
identified hits behave similarly. To achieve this, we first analyzed
the cytological characteristics of transduced and sorted
CD150+CD48Lin cells after a 7 day in vitro culture period (prior
to their transplantation). In this context, cultures initiated with
control vector-transduced cells contained 70% ± 8%of differen-
tiated cells. These included neutrophils, monocytes, and mast
cells (Figure 4A, arrows in upper-left panel with summary of
results in right panel). Conversely, cellular differentiation was
reduced in cultures initiated with HSCs transduced with most
of the candidates (Figure 4A, right panel). The increase in the
proportion of undifferentiated to differentiated cells was most
important for Vps72, Fos, Sox4, Klf10, Ski, Prdm16, Erdr1, and
Sfpi1 when compared to cultures initiated with control vector-
transduced HSCs (see blue bars exceeding shaded area, repre-senting mean of vector plus two standard deviations). Note that
while some of these genes are as potent as Hoxb4 in this assay,
none exceeds NA10HD in keeping cells undifferentiated.
We also monitored transduced CD150+CD48Lin cells for
cell death and proliferation. Figure 4B shows that all factors
analyzed conferred a significant reduction in the proportion of
dead cells harvested at day 4 of culture. Surprisingly, besides
Hmgb1, there were no significant increases in total cell numbers
in these cultures (Figure 4C). In fact, some genes such asHoxb4,
and possibly NA10HD, were associated with a reduction in total
cell counts (Figure 4C).
Transduced HSCs Differentiate In Vivo
The in vitro differentiation arrest displayed by Hoxb4- or
NA10HD-transduced HSCs is eventually reverted after their
transplantation in vivo (Cellot et al., 2007; Ohta et al., 2007).
Thus, depending on the environment, these two genes can either
interfere with (e.g., in vitro in the presence of high levels of growth
factors) or not affect (e.g., in vivo under steady state conditions)
HSC differentiation. To determine whether the newly identified
regulators of HSC activity are similarly permissive to HSC differ-
entiation in vivo, we used four different approaches. First, we
evaluated the general health, spleen size, and bone phenotype
(white versus red) of each recipient. Except for the recipients of
Prdm16-transduced cells, which eventually developed spleno-
megaly and myeloproliferation with white femurs at 20 weeks
after transplantation (data not shown), none of the mice trans-
planted with cells expressing our nine other genes ever pre-
sented this or any other hematological phenotype. Second, we
performed cytological evaluation of bone marrow and spleen
derived from representative mice for each gene. Results from
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Prdm16 cohort, which showed an excess of poorly differentiated
myeloid cells in their bone marrow, as previously determined by
others (Shing et al., 2007), and the Ski cohort, in which the
number of lymphocytes in the bone marrow was reduced (data
not shown). Besides recipients of Prdm16-transduced cells,
spleens were never infiltrated with myeloid cells, nor did they
include enhanced numbers of erythroblasts. To confirm this,
we devised a third approach consisting of flow cytometry anal-
ysis on donor-derived (CD45.1+) cells. The results, presented
in Figure 5A for the peripheral blood, bone marrow, and thymus
of a representative mouse (Trim27) and summarized in Figure 5B
for all groups, largely confirmed our cytological evaluation.
Indeed, except for recipients of Ski-transduced cells, which
showed a marked reduction in B lymphocytes in their peripheral
blood and marrow with a compensatory increase in other cell
types, most groups of mice either showed normal distributions
of various cell types or presented some minor variations. We
further extended this analysis by gating only on CD45.1+/GFP+
cells for genes in which this was possible and ended with the
same conclusions, with the exception that B cell differentiation
was not observed in Klf10-transduced cells (Figure S3A). Finally,
clonal analyses of recipients that were reconstituted with retro-
virally marked cells were performed on bone marrow (less than
5% T cells) and thymus (less than 5% non-T cells). A representa-
tive result is presented in Figure 5C for Trim27, showing that
identical clones contributed to the reconstitution of these two
tissues, thus reinforcing the finding that these transduced
HSCs remain competent in T cell differentiation although they
displayed enhanced reconstitution activity. This finding can be
extended to all other genes except for Ski, Prdm16, and Erdr1,
for which we cannot be certain that the same clone contributed
to thymic and bone marrow reconstitution (Figure S3B).
We also used quantitative RT-PCR assays to monitor overex-
pression levels of the different transgenes in CD150+CD48Lin,
CD150+CD48+Lin, B, and myeloid cells isolated from bone
marrow to verify whether the in vivo reversal of the differentiation
arrest noted in vitro (as shown in Figure 4A) was associated with
loss of transgene expression. Results presented in Figure 5D
suggest that overexpression of Vps72, Fos, Sox4, Klf10, Ski,
Erdr1, and Sfpi1 does not interfere with in vivo differentiation
as several types of immature/differentiated cells still express
the transgene. However, in vivo extinction of the transgene
may have occurred for the three following genes: Smarcc1,
Trim27, and Prdm16.
Together, these results confirm that the majority of the Hoxb4-
like genes identified in our screen conferred enhanced HSC
activity without causing hematological diseases or profoundly
altering cell differentiation, while still overexpressing the trans-
genes at least until 20 weeks after transplantation. Prdm16
was a notable exception.
Evidence of Self-Renewal Divisions by Transduced
HSCs
We next verified whether HSCs transduced with each of the
confirmed hits remained capable of symmetrical self-renewal
divisions in vitro. To address this, we performed clonal analysis
(i.e., proviral integration pattern) of hematopoietic tissues
derived from selected recipients that were highly reconstituted374 Cell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc.(17%–83% CD45.1+ cells) at 20 weeks after transplantation,
a time point deemed sufficient for inferring that reconstitution
is solely derived from the LT-HSC. For eight of the ten newly
identified Hoxb4-like genes, namely Smarcc1, Vps72, Trim27,
Sox4, Klf10, Ski, Prdm16, and Erdr1, we observed proviral
DNA in the vast majority of mice that were analyzed (i.e., 43/49;
Figure 6, two upper panels). Several different clones with long-
term reconstitution ability contributed to hematopoiesis among
different recipients from a given experiment, and from subse-
quent validation experiments. In several instances, we could
identify the same proviral integrations in the DNA from two
different mice reconstituted by cells derived from the same
culture, demonstrating that LT-HSC self-renewal has indeed
occurred in these cultures (see ‘‘a’’–‘‘g’’ in Figure 6). We also
performed this analysis with the less potent candidates and
found evidence for HSC self-renewal for Cnbp and Xbp1 (see
clones ‘‘h’’ and ‘‘i’’ in Figure 6). Together, these data indicate
that a significant proportion of HSCs engineered to overexpress
our validated hits remained capable of symmetrical self-renewal
divisions in vitro.
Evidence of a Non-Cell-Autonomous Activity
for Selected Genes
Surprisingly, we could not reveal any integrated provirus in the
majority of recipients transplanted with cells transduced with
the Hoxb4-like genes Fos and Sfpi1 (Figure 6, bottom panels).
This suggests that untransduced HSCs in these cultures have
favorably responded to some extrinsic factors. A detailed evalu-
ation of recipients from which these observations are derived is
provided in Table S4. Consistent with the presence of a non-cell-
autonomous effect, we observed that upon exposure to Fos or
Sfpi1 viral producer cells, HSC contribution to long-term repopu-
lation increased from 5%–6%after 5 days of infection (i.e., day 0)
to 26%–31% with 7 additional days of culture (Table S4,
compare %CD45.1 at day 0 [seventh column] to that at day 7
[eighth column]). The absence of Fos and Sfpi1 proviruses in
the hematopoietic system of long-term recipients is surprising
considering the high level of gene transfer to transplanted cells
(Table S4, third column). This possibly indicates that these genes
also intrinsically interfere with HSC repopulation when overex-
pressed, leading to depletion of transduced HSCs. Similar
observations were found with Tcfec and Hmgb1, members of
the less potent category (data not shown).
To provide more-direct evidence of non-cell-autonomous
activities for Fos, Sfpi1, Tcfec, and Hmgb1, we transduced
non-viral-producing NIH 3T3 cells with each of these constructs
and used them as feeder cells replacing the viral producers
described in Figure 1B. Overexpression of each of these four
factors in NIH 3T3 cells was verified by quantitative RT-PCR,
with a relative fold difference above baseline values ranging
from 3-fold (Hmgb1) to 18,000-fold (Tcfec) (data not shown).
As per our experimental protocol, 1500 CD150+CD48Lin cells
were seeded on non-viral-producing cells and maintained for
7 days prior to their transplantation into irradiated hosts. Strik-
ingly, we found that three of the four genes, namely Fos, Tcfec,
and Hmgb1, conferred a similar impact on HSC activity whether
viral-producing or non-viral-producing cells were present
in the cultures (see Table 1). Interestingly, background-level
Figure 5. In Vivo Differentiation Potential of HSCs Overexpressing Validated Hits
(A) In vivo differentiation potential along the lymphomyeloid lineages was assessed in long-term recipients (20 weeks after transplantation) of HSCs transduced
with Trim27, used as an example. Immunophenotypic analysis by flow cytometry was performed with specific antibodies against B, T, and myeloid cell surface
markers (B220, CD3, and CD11b, respectively) on the CD45.1+ population of cells derived from the peripheral blood, bone marrow (BM), and thymus of these
mice (and on CD45.1+/GFP+ cells in Figure S3A).
(B) Compilation of B-/T-lymphoid and myeloid cell percentages within the CD45.1+ population (left panels) and of CD45.1+ cell proportions in the B-lymphoid,
T-lymphoid, or myeloid populations (right panels) of blood, thymus, and BM tissues, as gathered in (A), for most of the primary hits. Values are presented as
mean ±SD. Mouse identification numbers are presented between brackets. Dashed lines indicate values obtained with control mice (vector) for the different
hematopoietic tissues. Note that multilineage reconstitution was observed in all of mice analyzed except for those transplanted with cells transduced with
Ski, which showed a block in B-lymphoid differentiation. The proportion of CD45.1+ cells within the B-lymphoid or myeloid populations in the thymus was not
calculated in the right panels because these populations represent less than 5% of total cells in this tissue. Since weak donor-derived reconstitution levels
were observed in mice transplanted with control vector cells at day 7 of culture (i.e., 4% in Figure 3A), we used mice transplanted with control vector cells at
day 0 of culture in this case. Values pertaining to less statistically significant hits are also presented (Tcfec, Zfp472, Hmgb1, Cnbp, Xbp1, Hnrpdl, and Hdac1).
(C) Proviral integration pattern studies by Southern blot analysis performed on genomic DNA extracted from bone marrow (left panel) and thymus (right panel) of
three long-term recipients of Trim27-overexpressing HSCs. Each lane represents a specific mouse (ID number below). For a given animal, identical integrations
are found in both tissues, indicating a common precursor cell origin. Identical clones are also observed in two distinct recipients, retrospective molecular
evidence for a self-renewal division in vitro. Multipotentiality (BM and thymus) analyses in reconstituted tissues harvested from primary recipients of culture cells
overexpressing the various validated hits are shown in Figure S3B.
(D) Quantitative RT-PCR analysis of mRNA expression levels of nine of the ten newly identified Hoxb4-like gene transcripts. For technical reasons, Prdm16 was
excluded from the analysis. RNA was extracted from distinct bone marrow cell fractions isolated from long-term, highly reconstituted recipients of day 7 culture
cells (S, CD150+CD48Lin; P, CD150+CD48+Lin; B, B220+; M, Mac+). Average DCt values (representative of expression levels) were determined with b-actin
serving as an endogenous control to normalize levels of target gene expression. Relative fold differences were determined using control cells as a reference cali-
brator for each candidate gene. Reactions were done in triplicate; black bars represent mean endogenous expression levels ±SEM of three independent wild-
type mice (Ctrl); red bars represent mean overexpression levels ±SEM of two transplanted mice (Trx) from two independent experiments. The identification
numbers of mice used in this assay are presented between brackets. Note that control black bars on each panel are set at a relative fold difference value of 1.Cell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc. 375
reconstitution was found in recipients of cells kept on Sfpi1-
transduced NIH 3T3 cells, possibly indicating a more complex
cellular network involved with this gene.
DISCUSSION
In this study, we combined the power of expression profiling and
functional studies to uncover candidate factors that impact on
HSC activity. Our experimental procedure included an efficient
production of high-titer retroviruses, a sharp and discriminating
HSC gain-of-function signal optimized by an ex vivo culture
step together with a robust and reliable in vivo assay (see impor-
tance of culture step for signal-to-noise discrimination in
Figure S4). Using this strategy, we individually tested 104 prese-
lected candidates revealing 18 genes that conferred a clear
repopulation advantage to HSCs. Of these, ten displayed
a Hoxb4-like effect, thereby greatly extending the repertoire of
potential regulators of HSC activity. These factors, which are
highly and in some case preferentially expressed in HSCs, are
Figure 6. Clonal Analysis to Track HSC
Self-Renewal Divisions
Southern blot analyses of genomic DNA extracted
from the bone marrow (BM) of selected long-term
recipients (20 weeks after transplantation) of day 7
culture cells. Each blot was hybridized with a GFP-
specific probe and systematically exposed for the
same period of time. Each well was equally
loaded, taking into consideration donor-derived
peripheral blood reconstitution level of recipients
as measured 16 weeks after transplantation (i.e.,
17%–83% CD45.1+ cells). Top and bottom panels
show gene sets for which proviral DNA was either
detected or absent in the majority of recipients
analyzed, respectively. For most bottom panels,
the brightness and contrast was enhanced using
Photoshop to further verify the absence of inte-
grated proviral DNA, and a b-actin probe was
also used to confirm the presence of genomic
DNA. Clones that self-renewed during the 7 day
culture, prior to transplantation, are labeled ‘‘a’’
to ‘‘i’’ and identified in more than one recipient.
‘‘X’’ indicates that GFP expression was not detect-
able for these constructs/clones. Note that panel
5, representing the Trim27 gene, is also included
in Figure 5C (left panel).
implicated in a diversity of processes,
such as chromatin modification (e.g.,
Smarcc1 and Vps72), stress response
(e.g., Fos), and gene transcription (e.g.,
Trim27 and Klf10) (see Table S4 and
legend for more details on these Hoxb4-
like factors). With this significant cohort
of genes impacting HSC activity, it was
possible to discern a subset of four
factors (i.e., Fos, Tcfec, Sfpi1 and
Hmgb1) that exerted their influence on
stem cell function through a non-cell-
autonomous phenomenon. Importantly,
the non-cell-autonomous activity of three of these four factors
was confirmed in gene transfer-free conditions.
Identified Hits Display Hoxb4-like HSC Activity
Similar to our previous results with Hoxb4-overexpressing
HSCs, nine of the ten hits identified in this screen also signifi-
cantly conferred increased HSC activity to levels above those
observed with input cells (genes in red in Figures 3B–3C).
Considering the 50% average gene transfer level, not taken
into consideration in the evaluation of the mean activity of stem
cells (MAS) reported in Figure 3B, the impact of some of our
confirmed hits was likely underestimated. Interestingly, our
newly identified candidates also induced a maturation block
in vitro, which was reversed in vivo. Moreover, and similar to
Hoxb4, the majority of these genes failed to enhance cellular
proliferation in vitro.
The increase in HSC repopulation potential (i.e., activity)
observed with Hoxb4 overexpression involves a net expansion
(self-renewal) of these cells (Antonchuk et al., 2002). Although376 Cell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc.
Table 1. HSC Activity Is Enhanced Extrinsically
GP+E86 (virus) NIH 3T3 (no virus)a
%GFP %CD45.1 %GFP %CD45.1
vector 62 ± 26 4 ± 1 0 ± 0 5 ± 2
Fos 71 ± 9 31 ± 8 0 ± 0 35 ± 14
Sfpi1 37 ± 17 26 ± 12 0 ± 0 2 ± 1
Tcfec 48 ± 21 22 ± 8 0 ± 0 13 ± 5
Hmgb1 22 ± 14 20 ± 10 0 ± 0 14 ± 5
Donor-derived reconstitution levels (%CD45.1+) observed 16 weeks after
transplantation in mice transplanted with cells cocultured either with
virus-producing cells (GP+E-86) or similar cells not producing virus
(NIH 3T3), both overexpressing selected genes. Values are presented
as mean ±SEM of independent experiments (n) per candidate gene,
where n = 4, except for control vector, where n = 8. For each independent
experiment, a mean of three mice per gene was evaluated.
aMice were analyzed at 16 (experiments 1 and 2) and 8 (experiments
3 and 4) weeks after transplantation; %GFP, gene transfer assessed by
flow cytometry.our validated candidates show Hoxb4-like effects and we could
document self-renewal divisions in vitro for several HSCs engi-
neered to express these genes (Figure 6), it is important to stress
that the formal proof for HSC expansion (enhancement in self-
renewal divisions) as the driving force behind these effects will
require intensive investigations that combine serial determina-
tions of HSC numbers at consecutive time points (e.g., DCRU
assay) with large-scale clonal analyses as previously reported
for the Hoxb4 gene (Antonchuk et al., 2002; Cellot et al., 2007).
Indeed, among several possibilities, enhancement in prolifera-
tive potential combined with in vitro HSC maintenance could
explain the Hoxb4-like effects observed with our validated hits.
Secondary transplantation assays performed with selected
candidates (Vps72, Klf10, Erdr1, and Fos, Table S5) argue
against, but do not refute, such a possibility.
The eventual identification of shared target genes between
these factors would further strengthen this argumentation. Of
interest, attempts to build transcriptional networks, or hubs,
among the hit genes have currently proven inconclusive, when
most of the respective mRNA expression levels were assessed
in HSCs freshly transduced with each of the candidate genes
(see http://www.bioinfo.iric.ca/self-renewal/Network/).
Non-Cell-Autonomous Enhancement in HSC Activity
The non-cell-autonomous influence exerted by Fos, Tcfec, and
Hmgb1 was confirmed in cultures with NIH 3T3 support, con-
firming that gene transfer to sorted HSCs was not required for
these three genes. In line with these findings, the proportion of
GFP-positive cells was 0% in recipients of cells kept for 7 days
in NIH 3T3-containing cultures (see column four in Table 1). It
is also important to stress that these so-called ‘‘non-cell-auton-
omous’’ factors were identified in a context of overexpression,
which in some cases (i.e., Fos) was outstanding (e.g., 38,000-
fold above endogenous levels in some experiments, data not
shown), potentially resulting in toxicities to transduced HSCs. It
is therefore likely that several of these factors normally perform
cell-autonomous activity in steady-state hematopoiesis. Sfpi1
is a notable example for this (Rosenbauer et al., 2006).The results obtained with Sfpi1 during the screen and several
additional experiments could not be confirmed in viral-free
cultures. Reasons for this remain unclear. Several possibilities
exist, including thepresenceofnon-cell-autonomouscontribution
by some differentiated hematopoietic cells found in our culture
or by essential cofactors unique to GP+E-86 viral producer cells.
These results thus raise critical questions about a possible, and
even essential, contribution by the feeder cells (in this case NIH
3T3) to the observed effects on HSC activity. While this level of
characterization is beyond the scope of our paper, this set of
experiments exposes a complexity, often underestimated, when
packaging (feeder) cell lines are used for cocultures in gene trans-
fer studies. Awareness of this potentially confounding factormust
therefore be taken into consideration in future experiments.
Although the demonstration of the non-cell-autonomous
activity is relatively straightforward (e.g., three of the four factors
described above), the proof for cell-autonomous function (e.g.,
the other newly identified factors) is more difficult to obtain within
the scope of our experimental design. Thus, it is possible that
some of the eight other Hoxb4-like genes (Smarcc1, Vps72,
Trim27, Sox4, Klf10, Ski, Prdm16, and Erdr1) also or only display
non-cell-autonomous activity.
Future of the Resource
Entries pertaining to candidate nuclear factors implicated in
stem cell activity are stored in an open-access database
(http://www.bioinfo.iric.ca/self-renewal/), as part of a building
block in creating an interactive resource for the scientific
community. Information thus far includes mRNA expression
profiles, together with specific probe and primer sets, blood
reconstitution patterns over timewith possibilities of data reanal-
ysis, and the complete nuclear factor list with ranking criteria.
This database will eventually include similar data emerging
from ongoing gain- and loss-of-function screens from different
laboratories that will exploit this resource.
Thus far, nuclear factor candidates clustering in the upper-
most levels (eight to ten) of our classification harbor a 23%
primary hit rate, compared to 12% for those scoring lower (six
to seven). This suggests that while positive HSC regulators
tend to segregate in the top ranks, other downstream genes
listed in our database (scores 1–5, n = 585 candidates) also
include potential determinants of HSC self-renewal, with puta-
tive derivation of cross-regulation nodes as mentioned.
Our understanding of HSC self-renewal will mirror advance-
ments in the rapidly evolving field of cellular therapy. As pio-
neered with Hoxb4 (Krosl et al., 2003a), recombinant TAT-fusion
proteins could be envisioned and therapeutically tested on
human cells. Moreover, findings from this work will potentially
pave the way to identify the mediator(s) that link these non-
cell-autonomous candidates to enhanced HSC activity, thereby
bypassing the requirement for retroviral vectors in the goal of
expanding HSCs for clinical purposes.
EXPERIMENTAL PROCEDURES
Retroviral Vectors
MSCV-Hoxb4-IRES-GFPandMSCV-NUP98-HOXA10HD-IRES-GFP (NA10HD)
were previously described (Antonchuk et al., 2001; Ohta et al., 2007). For allCell 137, 369–379, April 17, 2009 ª2009 Elsevier Inc. 377
candidate genes, single open reading frames (ORFs) were amplified by PCR
(see Table S2 and the Supplemental Experimental Procedures for details).
Animals
(C57Bl/6J-CD45.2 x C3H/HeJ) F1 recipient mice and (C57Bl/6J-CD45.1-
Pep3b x C3H/HeJ) F1 congenic donor mice were bred at a specific path-
ogen-free (SPF) animal facility at IRIC in Montreal.
CRU Assay on HSC-Enriched Populations
CRU assay and calculation were performed as described originally (Szilvassy
et al., 1990) with modifications as in Sauvageau et al. (1995). Recipients were
considered reconstituted (i.e., positive) when R1% of their peripheral blood
leukocytes were of donor (CD45.1+) origin at 18–20 weeks after transplanta-
tion. Two CRU assays were performed with CD150+CD48Lin cells and
one CRU assay for the CD150+CD48LincKit+Sca1+ subpopulation.
BoneMarrow Cell Culture, Retroviral Infection, and Transplantation
Generation of retrovirus-producing GP+E-86 cells, or gene-overexpressing
NIH 3T3, were performed as previously described (Krosl et al., 2003b) and
seeded in a 96-well plate format, enabling production of a single ecotropic
pseudotyped retrovirus per well (for GP+E-86). See the Supplemental Exper-
imental Procedures for details.
Flow Cytometry Assessment of Donor-Derived Hematopoiesis
The contribution of donor cells to peripheral blood reconstitution was deter-
mined at regular intervals after transplantation in individual recipients. See
the Supplemental Experimental Procedures for details.
Analysis of Proliferation and Cell Death
Transduced cells harvested at day 4 of culture with trypsinization were
counted with BD Trucount Tubes (BD Biosciences, San Jose, CA) according
to manufacturer’s guidelines, or stained with Alexa350-annexin V (Invitrogen
Molecular Probes, Eugene, OR) and propidium iodide (50 mg/ml) in accordance
with themanufacturer’s instructions. Individual well contents were analyzed by
flow cytometry. Gates were set to exclude GP+E86 retroviral producers by
forward- and side-scatter criteria.
Resource Database and Web Application
The open-source postgreSQL relational database engine was used to store
the accumulated data, and the web application was built with the open-source
Webware application server framework. The application is designed to house
results from other ongoing screens from our lab as well as screens performed
elsewhere. As such, a sections-based authentication system has been imple-
mented in order to restrict access to sensitive or nonpublished results. We
expect this website to become an open-access resource for teams working
on deciphering the molecular basis for stem cell self-renewal.
Statistical Analysis
The significance of differences was determined by a two-tailed Student’s
t test.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, five
figures, and six tables and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)00325-0.
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